Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1990 1
1991 1
1992 2
1994 4
1995 4
1996 4
1997 1
1998 7
1999 4
2000 1
2001 8
2002 3
2003 1
2004 4
2005 7
2006 5
2007 4
2008 1
2009 4
2010 5
2011 3
2012 4
2013 5
2014 8
2015 8
2016 6
2017 6
2018 3
2019 1
2020 5
2021 8
2022 7
2023 6
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJM, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A, Janikova A, Cwynarski K, Mikhaeel G, Jerkeman M, Di Rocco A, Stepanishyna Y, Vitolo U, Santoro A, Re A, Puccini B, Olivieri J, Petrucci L, Barrington SF, Malkowski B, Metser U, Versari A, Chauvie S, Walewski J, Trneny M, Cavalli F, Gospodarowicz M, Johnson PWM, Davies A, Zucca E; International Extranodal Lymphoma Study Group (IELSG). Martelli M, et al. J Clin Oncol. 2024 Dec;42(34):4071-4083. doi: 10.1200/JCO-24-01373. Epub 2024 Aug 19. J Clin Oncol. 2024. PMID: 39159403 Clinical Trial.
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F; International Extranodal Lymphoma Study Group (IELSG). Ferreri AJ, et al. Among authors: vallisa d. Lancet. 2009 Oct 31;374(9700):1512-20. doi: 10.1016/S0140-6736(09)61416-1. Epub 2009 Sep 18. Lancet. 2009. PMID: 19767089 Free article. Clinical Trial.
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Arcari A, Rigacci L, Tucci A, Puccini B, Usai SV, Cavallo F, Fabbri A, Balzarotti M, Pelliccia S, Luminari S, Pennese E, Zilioli VR, Mahmoud AM, Musuraca G, Marino D, Sartori R, Botto B, Gini G, Zanni M, Hohaus S, Tarantini G, Flenghi L, Tani M, Di Rocco A, Merli M, Vallisa D, Pagani C, Nassi L, Dessì D, Ferrero S, Cencini E, Bernuzzi P, Mammi C, Marcheselli L, Tabanelli V, Spina M, Merli F. Arcari A, et al. Among authors: vallisa d. Blood Adv. 2023 Aug 8;7(15):4160-4169. doi: 10.1182/bloodadvances.2023009839. Blood Adv. 2023. PMID: 37276080 Free PMC article.
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).
Breccia M, Palandri F, Martelli M, Mendicino F, Malato A, Palumbo GA, Sibilla S, Di Renzo N, Abruzzese E, Siragusa S, Crugnola M, Selleri C, Pane F, Sportoletti P, Martino B, Impera S, Ricco A, Langella M, Ditonno P, Carli G, Itri F, Liberati AM, Urbano T, Tafuri A, Polizzi V, Pastore D, Morsia E, Benevolo G, Micucci G, Farina G, Bonifacio M, Elli EM, Gardellini A, De Stefano V, Caocci G, Falcone AP, Vallisa D, Brociner M, Tiribelli M, Binotto G, Pocali B, Cavazzini F, Tomassetti S, Lunghi F, Di Ianni M, Allegra A, Anaclerio B, Mazzotta S, Orofino N, Gherlinzoni F, Castiglioni C, Landoni M, Valsecchi D, Magnoli M, Guglielmelli P, Passamonti F. Breccia M, et al. Among authors: vallisa d. Cancer. 2025 Apr 1;131(7):e35801. doi: 10.1002/cncr.35801. Cancer. 2025. PMID: 40111826 Free PMC article.
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Papayannidis C, Petracci E, Zappasodi P, Fracchiolla N, Ciceri F, Sartor C, Roncoroni E, Di Raimondo F, Mattei D, Giannini MB, Lanza F, Gottardi M, Del Principe MI, Borlenghi E, Fumagalli M, Vallisa D, Sica S, Di Renzo N, Fabbiano F, Todisco E, de Fabritiis P, Luppi M, Passamonti F, Corradini P, Petruzziello F, Pane F, Ferrara F, Mambelli G, Volpi R, Frabetti F, Zingaretti C, Marconi G, Martinelli G. Papayannidis C, et al. Among authors: vallisa d. Cancer. 2025 Apr 1;131(7):e35820. doi: 10.1002/cncr.35820. Cancer. 2025. PMID: 40120068 Free PMC article.
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry-Based Study on Behalf of the "Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare" (GITMO).
Defrancesco I, Ferretti VV, Chiusolo P, Russo D, Nozzoli C, Olivieri A, Gambella M, Cavattoni IM, Bramanti S, Santarone S, Fanin R, Cairoli R, Piemontese S, Parma M, Onida F, Busca A, Castagna L, Cuoghi A, Pastore D, Mordini N, Benedetti F, Skert C, Borghero C, Iori AP, Fagioli F, Pavone V, Selleri C, Cesaro S, Musso M, Ladetto M, Vallisa D, Carluccio P, Picardi A, Tozzi M, Biffi A, Milone G, Faraci M, Prete A, Prezioso L, Risitano AM, Tambaro FP, Tintori V, Galieni P, Pane F, Zerbi C, Bianchessi A, Losi G, Romano F, Taurino A, Oldani E, Polverelli N, Bonifazi F, Martino M. Defrancesco I, et al. Among authors: vallisa d. Am J Hematol. 2025 Aug;100(8):1354-1364. doi: 10.1002/ajh.27731. Epub 2025 Jun 2. Am J Hematol. 2025. PMID: 40456127 Free PMC article.
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.
Tiacci E, Mancini A, Marchetti M, D'Elia GM, Candoni A, Morotti A, Romano A, Gozzetti A, Broccoli A, De Carolis L, Bruna R, Tisi MC, Selleri C, Capponi M, Vallisa D, Cattaneo C, Della Porta MG, Busca A, Falini B, Massaia M, Bertù L, Pulsoni A, Rivela P, Corradini P, Passamonti F. Tiacci E, et al. Among authors: vallisa d. Br J Haematol. 2023 May;201(3):411-416. doi: 10.1111/bjh.18606. Epub 2022 Dec 20. Br J Haematol. 2023. PMID: 36541031 Free PMC article.
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting.
Nanni J, Azzali I, Papayannidis C, Mulè A, Audisio E, Martelli MP, Scappini B, Chiusolo P, Cambò B, Candoni A, Lunghi M, Albano F, Olivieri A, Fracchiolla N, Bernardi M, Romani C, Rigolin GM, Giannini MB, Bocchia M, Todisco E, Cilloni D, Bochicchio MT, Ottaviani E, Mattei A, Zamagni F, Valli I, Volpi R, Marconi G, Petracci E; FLAM Collaborative Group; Martinelli G. Nanni J, et al. Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824. Cancer. 2025. PMID: 40159434 Free PMC article.
138 results